🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Primary Objective: To evaluate the efficacy of dupilumab, compared with pl...
Status
Completed
Location
Investigational Site Number 840022
Start Date
2015-10-15
Trial ID
NCT02528214
This study planned to assess the effect on the reduction in rate of severe ...
Status
Terminated
Location
Novartis Investigative Site
Start Date
2015-09
Trial ID
NCT02336425
This interventional, open study will evaluate clinical data in relation to ...
Status
Completed
Location
Multiple Locations
Start Date
2013-07
Trial ID
NCT01948401
Treatments Being Tested
This randomized, multicenter, double-blind, placebo-controlled, parallel-gr...
Status
Completed
Location
Kern Allergy Med Clinic, Inc.
Start Date
2014-02-28
Trial ID
NCT01987492
Treatments Being Tested
This is a prospective, real-world, single arm, global, multi-centre study t...
Status
Active Not Recruiting
Location
GSK Investigational Site
Start Date
2024-03-20
Trial ID
NCT06041386
Treatments Being Tested
The purpose of this trial is to confirm if benralizumab can reduce the use ...
Status
Completed
Location
Research Site
Start Date
2014-04-28
Trial ID
NCT02075255
Treatments Being Tested
The objectives of this study are to use the Delphi method to assemble an ex...
Status
Unknown
Location
Association Jean Baptiste Desbrest
Start Date
2019-04-01
Trial ID
NCT03899740
Treatments Being Tested
This study will assess whether switching participants who have benefitted f...
Status
Completed
Location
GSK Investigational Site
Start Date
2021-01-26
Trial ID
NCT04718389
The main purpose of this study is to investigate whether dupilumab is effec...
Status
Completed
Location
Regeneron study Site
Start Date
2020-10-28
Trial ID
NCT04206553
Treatments Being Tested
This is a randomised, double-blind, placebo-controlled, parallel-group, mul...
Status
Completed
Location
GSK Investigational Site
Start Date
2012-10
Trial ID
NCT01691508
Treatments Being Tested